With the analysis among 17,607 patents, we discovered top 449 key players by total patent application. Regeneron Pharmaceuticals, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novartis AG are dominant in this area. They take 14.41% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1,336
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 644
Basel-Stadt, Switzerland
Patent: 558
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 544
Louisiana, United States
Patent: 430
New York, United States
Patent: 345
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 337
Cambridgeshire, United Kingdom
Patent: 331
Indiana, United States
Patent: 278
With the analysis among 750 patents, we discovered top 67 start-ups by total patent application. Phanes Therapeutics, Inc., Pionyr Immunotherapeutics, Inc., Verseau Therapeutics, Inc. are active in this area.
Phanes Therapeutics, Inc.
California, United States
Patent: 114
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 43
Verseau Therapeutics, Inc.
Massachusetts, United States
Patent: 39
Black Belt Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 36
Massachusetts, United States
Patent: 35
Lombardia, Italy
Patent: 31
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 29
Tokyo-to, Japan
Patent: 26
OriCell Therapeutics Co.,Ltd.
Massachusetts, United States
Patent: 23
With the analysis among related 9,891 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd. take 15.10% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 548
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 521
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 425
Basel-Stadt, Switzerland
Patent: 207
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 179
New York, United States
Patent: 177
Louisiana, United States
Patent: 136
Ticino, Switzerland
Patent: 134
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 131
With the analysis among related 9,891 patents in last 5 years, we discover 262 new entrants. Phanes Therapeutics, Inc., BeiGene Ltd., ABL Bio, Inc. are the most active new entrants in this area.
Phanes Therapeutics, Inc.
California, United States
Patent: 114
Massachusetts, United States
Patent: 76
Gyeonggi-do, South Korea
Patent: 67
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 66
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 65
Five Prime Therapeutics, Inc.
California, United States
Patent: 64
California, United States
Patent: 60
Shandong Boan Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 58
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 44
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 43
With the analysis among 2,325 patents, we discovered top 170 universities and scientific research institutions by total patent application. Massachusetts Institute of Technology, The Johns Hopkins University, Yale University are dominant in this area. They take 17.59% of the total patent filing.
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 50
The Johns Hopkins University
Connecticut, United States
Patent: 45
The Rockefeller University
New York, United States
Patent: 41
ZURICH, Switzerland
Patent: 37
The Scripps Research Institute
California, United States
Patent: 34
North Carolina, United States
Patent: 31
Tokyo-to, Japan
Patent: 30
Osaka-fu, Japan
Patent: 27